Showing 1991-2000 of 2793 results for "".
- First-ever Data on Vaginal Regeneration for ThermiVahttps://modernaesthetics.com/news/first-ever-data-on-vaginal-regeneration-for-thermiva/2472081/Thermi’s ThermiVa® device has been shown to deliver significant improvements in common vaginal disorders and improve sexual satisfaction, according to a study published in Dermatologic Surgery. Since it was cleared by the FDA in 2013, ThermiVa has been used in more t
- New ASPS Data: Minimally Invasive Aesthetic Procedures Up 200 Percent Since 2000https://modernaesthetics.com/news/new-asps-data-minimally-invasive-aesthetic-procedures-up-200-percent-since-2000/2472125/Drumroll, please… Plastic surgery is on the rise, according to the annual statistics from the American Society of Plastic
- Valentine's Day and Beyond: Lip Enhancement on the Risehttps://modernaesthetics.com/news/valentines-day-and-beyond-lip-enhancement-on-the-rise/2472133/The big talk after the recent Grammy Awards wasn’t Hillary Clinton’s cameo or Lady Gaga’s incredible performance, it was Kendall Jenner’s seriously plump pucker. The Twitterverse lit up with accusations about what the 22-year-old did or didn’t do to achieve s
- Jacob Chacko, MD Joins Bonti's Board of Directorshttps://modernaesthetics.com/news/jacob-chackomd-joins-bontis-board-of-directors/2472135/Jacob Chacko, MD has joined Bonti’s Board of Directors. Dr. Chacko has served as the Chief Financial Officer of Ignyta, Inc. since May 2014. At Ignyta, he leads multiple functions, including Finance, Accounting, Investor Relations, Comm
- Cynosure's TempSure™ Envi Set to Debut at 2018 AAD Meetinghttps://modernaesthetics.com/news/cynosures-tempsure-envi-set-to-debut-at-2018-aad-meeting/2472144/Hologic's Cynosure division is launching TempSure™ Envi – an FDA-cleared advanced radiofrequency device. TempSure™ Envi heats the deep layers of skin to regenerate collagen and
- Investigational Neurotoxin Achieves 6-Month Duration in Phase 3: Revancehttps://modernaesthetics.com/news/investigational-neurotoxin-achieves-6-month-duration-in-phase-3-revance/2472157/Revance Therapeutics’ next-generation neuromodulator DaxibotulinumtoxinA for Injection (RT002) delivered positive top-line results in alleviating moderate-to-severe glabellar lines in two pivotal SAKURA Phase 3 trials with duraction of effect up to 6 months. RT002 appeared generally safe an
- FDA OKs Describe Patch for Use with All Tattoo Removal Lasershttps://modernaesthetics.com/news/fda-oks-describe-patch-for-use-with-all-tattoo-removal-lasers/2472158/Merz North America’s DESCRIBE® PFD Patch is now cleared by the Food and Drug Administration (FDA) for all commonly used lasers for tattoo removal. The new FDA c
- Congrats! Lisa M. Donofrio, MD Named New ASDS/ASDSA Presidenthttps://modernaesthetics.com/news/congrats-lisa-m-donofrio-md-named-new-asdsasdsapresident/2472179/Lisa M. Donofrio, MD, is the new President of the American Society for Dermatologic Surgery (ASDS) and American Society for Dermatologic Surgery Association (ASDSA). Along with her fellow officers and the ASDS / ASDSA
- Sculpture OK'd as Double Chin Treatmenthttps://modernaesthetics.com/news/sculpsure-oked-as-double-chin-treatment/2472190/Cynosure's SculpSure® is now cleared for submental fat reduction. The U.S. Food and Drug Administration (FDA) granted an expanded FDA 510(k) clearance for this area, Hologic, Inc. reports.
- Allergan Upgrades Brilliant Distinctions® Patient Loyalty Programhttps://modernaesthetics.com/news/allergan-upgrades-brilliant-distinctions-patient-loyalty-program/2472200/Allergan is launching the next generation of its U.S.-based Brilliant Distinctions® program. The new offering incorporates digital innovation to enhance the consumer experience and dr